Cargando…
The Investigation of Drug Resistance Substitutions in NS3 Protease Sequence of Hepatitis C Virus from Non-Responder Patients
BACKGROUND: Even with the fantastic successes of direct-acting antivirals (DAA) in the treatment of Hepatitis C Virus (HCV) infection, natural drug resistance remains a challenging obstacle for their impacts. The data regarding protease inhibitors (PIs) resistance in Iran population are limited. The...
Autores principales: | Nejabat, Nargess, Hosseini, Seyed Younes, Sarvari, Jamal, Gorzin, Ali Akbar, Fattahi, Mohammad Reza, Rasoolian, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852801/ https://www.ncbi.nlm.nih.gov/pubmed/31450900 http://dx.doi.org/10.31557/APJCP.2019.20.8.2311 |
Ejemplares similares
-
Analysis of TLR7, SOCS1 and ISG15 immune genes expression in the peripheral blood of responder and non-responder patients with chronic Hepatitis C
por: Dowran, Razieh, et al.
Publicado: (2017) -
Comparison of pre-S1/S2 variations of hepatitis B virus between asymptomatic carriers and cirrhotic/hepatocellular carcinoma-affected individuals
por: Taghiabadi, Mohammad, et al.
Publicado: (2019) -
Analysis of Naturally Occurring Resistant Mutations to Hepatitis C Virus NS3 Protease Inhibitors: A Preliminary Study in South of Iran
por: Afrasiabi, Mozhgan, et al.
Publicado: (2015) -
Association of PD-1 gene with outcome of hepatitis C virus infection
por: Sarvari, Jamal, et al.
Publicado: (2018) -
Polymorphism Analysis of Interleukin-18 and Interleukin-37 Genes in Hepatitis B Infections with Different Outcomes: A Preliminary Report from an Iranian Population
por: Molaei, Vahid, et al.
Publicado: (2023)